Common Stock, Shares, Issued of Viracta Therapeutics, Inc. from 31 Oct 2010 to 30 Sep 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Viracta Therapeutics, Inc. quarterly Common Stock, Shares, Issued in shares history and change rate from 31 Oct 2010 to 30 Sep 2024.
  • Viracta Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending 30 Sep 2024 was 39,744,222, a 2.9% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

Viracta Therapeutics, Inc. Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 39,744,222 +1,119,669 +2.9% 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 39,417,171 +836,817 +2.2% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 39,272,434 +861,499 +2.2% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 39,093,509 +748,369 +2% 31 Dec 2023 10-Q 13 Nov 2024 2024 Q3
Q3 2023 38,624,553 +721,704 +1.9% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 38,580,354 +1,026,041 +2.7% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 38,410,935 +924,758 +2.5% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 38,345,140 +920,277 +2.5% 31 Dec 2022 10-K 07 Mar 2024 2023 FY
Q3 2022 37,902,849 +621,623 +1.7% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 37,554,313 +413,496 +1.1% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 37,486,177 +449,883 +1.2% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 37,424,863 +36,518,876 +4031% 31 Dec 2021 10-K 14 Mar 2023 2022 FY
Q3 2021 37,281,226 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 37,140,817 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 37,036,294 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 905,987 +262,789 +41% 31 Dec 2020 10-K 17 Mar 2022 2021 FY
Q4 2019 643,198 -36,830,802 -98% 31 Dec 2019 8-K/A 23 Mar 2021
Q4 2018 37,474,000 +3,183,000 +9.3% 31 Dec 2018 10-K 10 Mar 2020 2019 FY
Q4 2017 34,291,000 +13,366,000 +64% 31 Dec 2017 10-K 07 Mar 2019 2018 FY
Q4 2016 20,925,000 +6,505,000 +45% 31 Dec 2016 10-K 09 Mar 2018 2017 FY
Q4 2015 14,420,000 -51,682,000 -78% 31 Dec 2015 10-K 09 Mar 2017 2016 FY
Q4 2014 66,102,000 +11,758,000 +22% 31 Dec 2014 10-K 14 Mar 2016 2015 FY
Q4 2013 54,344,000 +2,779,000 +5.4% 31 Dec 2013 10-K 12 Mar 2015 2014 FY
Q4 2012 51,565,000 +4,791,000 +10% 31 Dec 2012 10-K 06 Mar 2014 2013 FY
Q3 2012 3,306,541 30 Sep 2012 10-Q 08 Nov 2012 2012 Q3
Q4 2011 46,774,000 +1,402,000 +3.1% 31 Dec 2011 10-K 13 Mar 2013 2012 FY
Q4 2010 45,372,000 31 Dec 2010 10-K 14 Mar 2012 2011 FY
Q3 2010 7,357,610 31 Oct 2010 10-K 06 Mar 2014 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.